BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen M, Rosenberg J, Cai X, Hsuan Lee AC, Shi J, Nguyen M, Wignakumar T, Mirle V, Edobor AJ, Fung J, Donington JS, Shanmugarajah K, Lin Y, Chang E, Randall G, Penaloza-MacMaster P, Tian B, Madariaga ML, Huang J. Nanotraps for the containment and clearance of SARS-CoV-2. Matter 2021;4:2059-82. [PMID: 33907732 DOI: 10.1016/j.matt.2021.04.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu Z, Han Z, Jin X, An J, Kim J, Chen W, Kim JS, Zheng J, Deng J. Regulating the microenvironment with nanomaterials: Potential strategies to ameliorate COVID-19. Acta Pharm Sin B 2023. [PMID: 36846153 DOI: 10.1016/j.apsb.2023.02.010] [Reference Citation Analysis]
2 Zhang J, Han J, Li H, Li Z, Zou P, Li J, Zhao T, Che J, Yang Y, Yang M, Wang Y, Gong W, Li Z, Li L, Gao C, Xiao H. Lymphocyte Membrane- and 12p1-Dual-Functionalized Nanoparticles for Free HIV-1 Trapping and Precise siRNA Delivery into HIV-1-Infected Cells. Adv Sci (Weinh) 2023;:e2300282. [PMID: 36755201 DOI: 10.1002/advs.202300282] [Reference Citation Analysis]
3 Kotarkonda LK, Sinha TP, Bhoi S, Bharathala S. Role of nanocomposites for the prevention and treatment of viral infections in the health care system. Smart Nanomaterials to Combat the Spread of Viral Infections 2023. [DOI: 10.1016/b978-0-323-99148-3.00012-1] [Reference Citation Analysis]
4 Gupta G, Hamawandi B, Sheward DJ, Murrell B, Hanke L, McInerney G, Blosi M, Costa AL, Toprak MS, Fadeel B. Silver nanoparticles with excellent biocompatibility block pseudotyped SARS-CoV-2 in the presence of lung surfactant. Front Bioeng Biotechnol 2022;10:1083232. [PMID: 36578508 DOI: 10.3389/fbioe.2022.1083232] [Reference Citation Analysis]
5 Li Y, Xu S, Ye Q, Chi H, Guo Z, Chen J, Wu M, Fan B, Li B, Qin CF, Liu Z. Rational Development of Hypervalent Glycan Shield-Binding Nanoparticles with Broad-Spectrum Inhibition against Fatal Viruses Including SARS-CoV-2 Variants. Adv Sci (Weinh) 2023;10:e2202689. [PMID: 36377484 DOI: 10.1002/advs.202202689] [Reference Citation Analysis]
6 Yan Z, Li X, Ma Y, Ding H. Effect of the Graphene Nanosheet on Functions of the Spike Protein in Open and Closed States: Comparison between SARS-CoV-2 Wild Type and the Omicron Variant. Langmuir 2022. [DOI: 10.1021/acs.langmuir.2c02316] [Reference Citation Analysis]
7 Obeng EM, Fianu I, Danquah MK. Multivalent ACE2 engineering-A promising pathway for advanced coronavirus nanomedicine development. Nano Today 2022;46:101580. [PMID: 35942040 DOI: 10.1016/j.nantod.2022.101580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Mostafavi E, Iravani S, Varma RS. Nanosponges: An overlooked promising strategy to combat SARS-CoV-2. Drug Discov Today 2022;27:103330. [PMID: 35908684 DOI: 10.1016/j.drudis.2022.07.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Tu B, Gao Y, An X, Wang H, Huang Y. Localized delivery of nanomedicine and antibodies for combating COVID-19. Acta Pharm Sin B 2022. [PMID: 36168329 DOI: 10.1016/j.apsb.2022.09.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhou X, Chen X, Xue Z, Wang T. Nanoparticle assembled structures for matter assays in human flowing systems. Matter 2022;5:2760-86. [DOI: 10.1016/j.matt.2022.05.032] [Reference Citation Analysis]
11 J A, Girigoswami A, Girigoswami K. Versatile Applications of Nanosponges in Biomedical Field: A Glimpse on SARS-CoV-2 Management. Bionanoscience 2022;:1-14. [PMID: 35755139 DOI: 10.1007/s12668-022-01000-1] [Reference Citation Analysis]
12 Carey TR, Kozminsky M, Hall J, Vargas-Zapata V, Geiger K, Coscoy L, Sohn LL. Detecting Intact Virus Using Exogenous Oligonucleotide Labels. Anal Chem 2022. [PMID: 35584293 DOI: 10.1021/acs.analchem.2c00835] [Reference Citation Analysis]
13 Tu B, Wang H, An X, Qu J, Li Q, Gao Y, Shi M, Qiu H, Huang Y. Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants. Acta Pharm Sin B 2022. [PMID: 35169535 DOI: 10.1016/j.apsb.2022.01.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Xu W, Xu N, Zhang M, Wang Y, Ling G, Yuan Y, Zhang P. Nanotraps based on multifunctional materials for trapping and enrichment. Acta Biomater 2022;138:57-72. [PMID: 34492372 DOI: 10.1016/j.actbio.2021.08.047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Saha P, Bose S, Javed MN, Srivastava AK. Clinical potential of nanotechnlogy as smart therapeutics: A step toward targeted drug delivery. Advances in Nanotechnology-Based Drug Delivery Systems 2022. [DOI: 10.1016/b978-0-323-88450-1.00024-7] [Reference Citation Analysis]
16 Huang S, Zhu Y, Zhang L, Zhang Z. Recent Advances in Delivery Systems for Genetic and Other Novel Vaccines. Adv Mater 2021;:e2107946. [PMID: 34914144 DOI: 10.1002/adma.202107946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Ren M, Wang Y, Luo Y, Yao X, Yang Z, Zhang P, Zhao W, Jiang D. Functionalized Nanoparticles in Prevention and Targeted Therapy of Viral Diseases With Neurotropism Properties, Special Insight on COVID-19. Front Microbiol 2021;12:767104. [PMID: 34867899 DOI: 10.3389/fmicb.2021.767104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kozminsky M, Carey TR, Sohn LL. DNA-Directed Patterning for Versatile Validation and Characterization of a Lipid-Based Nanoparticle Model of SARS-CoV-2. Adv Sci (Weinh) 2021;8:e2101166. [PMID: 34672117 DOI: 10.1002/advs.202101166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Abbas M, Alqahtani MS, Almohiy HM, Alqahtani FF, Alhifzi R, Jambi LK. The Potential Contribution of Biopolymeric Particles in Lung Tissue Regeneration of COVID-19 Patients. Polymers (Basel) 2021;13:4011. [PMID: 34833310 DOI: 10.3390/polym13224011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Cai X, Chen M, Prominski A, Lin Y, Ankenbruck N, Rosenberg J, Nguyen M, Shi J, Tomatsidou A, Randall G, Missiakas D, Fung J, Chang EB, Penaloza-MacMaster P, Tian B, Huang J. A Multifunctional Neutralizing Antibody-Conjugated Nanoparticle Inhibits and Inactivates SARS-CoV-2. Adv Sci (Weinh) 2022;9:e2103240. [PMID: 34761549 DOI: 10.1002/advs.202103240] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Wang Z, Xiang L, Lin F, Cai Z, Ruan H, Wang J, Liang J, Wang F, Lu M, Cui W. Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm. Matter 2021. [PMID: 34693277 DOI: 10.1016/j.matt.2021.09.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
22 Liu H, Zhong W, Zhang X, Lin D, Wu J. Nanomedicine as a promising strategy for the theranostics of infectious diseases. J Mater Chem B 2021;9:7878-908. [PMID: 34611689 DOI: 10.1039/d1tb01316e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Heinen N, Klöhn M, Steinmann E, Pfaender S. In Vitro Lung Models and Their Application to Study SARS-CoV-2 Pathogenesis and Disease. Viruses 2021;13:792. [PMID: 33925255 DOI: 10.3390/v13050792] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]